SISCAPA Assay Technologies this week appointed Gustavo Salem to its board of directors and hired Ian Wright as a consultant and primary architect of diagnostic business strategy.
Salem was previously vice president and general manager of LC/MS at Agilent Technologies. Before that he was president and CEO of Assay Designs. He was also division manager of the Protein Separations Division at Bio-Rad.
Wright was previously head of the Strategic Innovation group and head of Global Assay Development at Siemens Healthcare Diagnostics.
Predictive Biosciences has named Pierre Cassigneul to be its new CEO, replacing Marc Schneebaum, who will return to his post as COO.
Cassigneul formerly was president, CEO, and vice chairman of the board at XDx, and he previously held management roles at Abbott Laboratories, Becton Dickinson, Bayer Diagnostics, and Ortho Diagnostic Systems. He also has served on the board of the Personalized Medicine Coalition.